Full Text View
Tabular View
Study Results
Related Studies
Study of Heart and Renal Protection (SHARP)
This study has been completed.
Study NCT00125593   Information provided by University of Oxford

First Received on July 29, 2005.   Last Updated on January 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Disease, Chronic
Additional conditions recognized in this trial
Chronic Disease
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Disease Attributes
Pathologic Processes
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
Simvastatin 20 mg
Ezetimibe 10mg
Placebo
Additional drug interventions recognized in this trial
Ezetimibe
Simvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Oxford
Merck
Schering-Plough
National Health and Medical Research Council, Australia
British Heart Foundation
Medical Research Council


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services